Adiprox-DT Tablet
Marketer
Adison Pharmaceuticals
Salt Composition
Piroxicam (20mg)
Overview Adiprox-DT Tablet
Arthrox Relief tablets offer effective pain management for moderate to severe aches associated with conditions like osteoarthritis and rheumatoid arthritis. This medication targets joint and muscle pain and inflammation. For optimal comfort, take Arthrox Relief with food to minimize stomach upset. Dosage and treatment length are determined by your specific needs and response. Continue using the medication as directed by your physician, even if symptoms improve, until advised to discontinue. Common side effects may include mild nausea, vomiting, stomach discomfort, headache, or dizziness. Report any persistent or worsening side effects to your doctor, who can offer strategies for symptom management. Prior to use, inform your doctor of any pre-existing conditions such as ulcers, heart problems, hypertension, or liver/kidney disease. Also, disclose all other medications you are currently using, as interactions are possible. Pregnant or breastfeeding individuals should seek medical advice before using Arthrox Relief.
Uses of Adiprox-DT Tablet
Analgesia
Major Benefits of Adiprox-DT Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Adiprox-DT Tablet in water before consumption. It should be administered with food.
Common Side effects of Adiprox-DT Tablet:
- Vomiting
- Stomach pain
- Nausea
- Headache
- Dizziness
How to use Adiprox-DT Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Adiprox-DT Tablet in water before consumption. This medication should be administered with food.
How Adiprox-DT Tablet works:
Adiprox-DT tablets contain a non-steroidal anti-inflammatory drug that inhibits the production of inflammatory mediators, thus reducing pain and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Adiprox-DT Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Adiprox-DT tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and Adiprox-DT Tablet use are likely incompatible. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving should be avoided if Adiprox-DT Tablet causes drowsiness, blurred vision, dizziness, or reduced awareness.
KidneyCAUTION
Patients with severe kidney impairment should use Adiprox-DT Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Adiprox-DT Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Adiprox-DT Tablet :
Should you forget a dose of Adiprox-DT Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Adiprox-DT Tablet
| Label | Value |
|---|---|
| Type of Compound | Carboxylic acid enolates |
| Addictive | None. |
| Treatment Category | Pain relievers |
FAQs on Adiprox-DT Tablet
Adiprox-DT Tablets and diclofenac are analgesics. Piroxicam, the active ingredient in Adiprox-DT, is a non-selective cyclooxygenase (COX) inhibitor, while diclofenac exhibits greater COX-2 selectivity. This increased COX-2 selectivity in diclofenac is believed to result in a reduced incidence of adverse effects relative to Adiprox-DT Tablets.
Naproxen and Adiprox-DT Tablet are both analgesics, non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain. Clinical trials demonstrate comparable efficacy for both medications. Nevertheless, naproxen exhibits a lower incidence of gastrointestinal adverse effects relative to Adiprox-DT Tablet.
Adiprox-DT Tablets and meloxicam are analgesics, both non-selectively inhibiting COX enzymes, the source of inflammation and pain. Clinical trials indicate comparable efficacy between the two. Nevertheless, meloxicam demonstrates a lower incidence of acute gastrointestinal adverse events relative to Adiprox-DT Tablets.
Adiprox-DT Tablets and ketoprofen are both analgesic medications that inhibit cyclooxygenase (COX), a key enzyme in inflammation and pain signaling. Clinical trials indicate superior efficacy and effectiveness for topical ketoprofen gel compared to Adiprox-DT Tablets. Furthermore, the gel demonstrated a high level of patient tolerance.
Adiprox-DT tablets contain a COX inhibitor, an enzyme that contributes to inflammation and pain, while Tramadol acts as an opioid analgesic. Tramadol carries a risk of dependence.
Adiprox-DT Tablet and nimesulide are analgesics. Adiprox-DT Tablet broadly inhibits COX enzymes, crucial in inflammation and pain signaling, while nimesulide's action is targeted to the COX-2 enzyme. This targeted mechanism in nimesulide is believed to reduce adverse reactions relative to piroxicam. Its use is contraindicated in children younger than twelve.
Chikungunya typically does not cause a decrease in platelet count. However, analgesics such as piroxicam may heighten the risk of bleeding. Therefore, avoid using Adiprox-DT Tablet or other pain relievers for fevers accompanied by joint pain. Seek medical advice prior to commencing Adiprox-DT Tablet treatment.
Adiprox-DT Tablets and aspirin are distinct medications, although both are classified as COX (cyclooxygenase) inhibitors, sharing anti-inflammatory and analgesic properties.
Concurrent use of Adiprox-DT tablets and dexamethasone is contraindicated due to their synergistic toxicity, significantly raising the probability of gastrointestinal ulceration.
Concurrent use of methocarbamol and Adiprox-DT tablets is considered safe, lacking documented significant adverse interactions. However, physician consultation prior to initiating either treatment is recommended.
Confirmation: Concurrent use of paracetamol and Adiprox-DT Tablet is acceptable, as no significant adverse reactions have been reported. Prior consultation with your physician is recommended before commencing either treatment.
Indeed, Adiprox-DT Tablet belongs to the class of non-steroidal anti-inflammatory drugs.
Adiprox-DT tablets contain sulfur. This medication may trigger serious side effects in susceptible patients, including severe skin reactions such as Stevens-Johnson syndrome. Always disclose any allergies to your physician.
Adiprox-DT Tablets do not possess anticoagulant properties; they are analgesics. Their use is contraindicated in individuals with hemorrhagic conditions.
Adiprox-DT Tablets do not relax muscles. This analgesic medication targets the COX enzyme (cyclooxygenase), an enzyme involved in the processes of inflammation and pain sensation.
Adiprox-DT Tablets are not classified as narcotics. This analgesic medication reduces pain and inflammation by targeting the COX enzyme, a key player in inflammatory processes.
Adiprox-DT Tablets are not indicated for hypertension management. Concomitant use with antihypertensive drugs reduces their efficacy. Disclose current antihypertensive medication use to your physician prior to commencing Adiprox-DT Tablet therapy.
Concomitant use of Adiprox-DT Tablet and Losartan is contraindicated. Adiprox-DT Tablet diminishes the efficacy of antihypertensive agents, such as Losartan, resulting in potential antihypertensive treatment failure when administered concurrently. Disclose current antihypertensive medication use to your physician prior to commencing Adiprox-DT Tablet therapy.
Concurrent use of Adiprox-DT Tablet and lisinopril is contraindicated. Piroxicam, a component of Adiprox-DT, diminishes the antihypertensive efficacy of lisinopril, potentially rendering antihypertensive treatment ineffective. Disclose your use of antihypertensive drugs to your physician prior to commencing Adiprox-DT Tablet therapy.
Confirmation: Adiprox-DT Tablets are compatible with calcium channel blockers. Studies indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) can lessen the efficacy of most antihypertensive medications, with calcium channel blockers being a noted exception (White, 2007).
Adiprox-DT Tablets can be used concurrently with tizanidine. Piroxicam, an analgesic, and tizanidine, a skeletal muscle relaxant, are suitable for conditions such as back pain.
Confirmed. Concomitant administration of Adiprox-DT Tablet and beta-cyclodextrin is feasible. Studies indicate this combination accelerates piroxicam's onset and diminishes gastrointestinal adverse reactions.
Affirmative. Alternative treatments to Adiprox-DT Tablet exist. Analgesic selection depends on the specific illness. A physician's consultation is necessary before commencing piroxicam therapy or switching medications.
Piroxicam should not be used in individuals with allergies to the drug, bleeding disorders, duodenal, gastric, or peptic ulcers, mouth sores, systemic lupus erythematosus, ulcerative colitis, upper gastrointestinal problems, late-stage pregnancy, heart conditions, liver dysfunction, or kidney dysfunction.
Adiprox-DT Tablets are not indicated for allergy treatment; they are an analgesic.
Adiprox-DT tablets provide extended pain relief with a single daily dose. However, individual responses vary, with the analgesic effects of piroxicam generally improving over several weeks of use.
Adiprox-DT Tablets are not associated with hypertension. This medication is a non-opioid analgesic.
Adiprox-DT tablets are not indicated for managing dysmenorrhea. Clinical trials demonstrate that piroxicam is highly effective in substantially reducing menstrual pain.
Adiprox-DT tablets lack regulatory approval for migraine treatment. Clinical trials indicate this medication effectively reduces the pain of migraine headaches lacking an aura.
Affirmative. This medication may alleviate back pain. Nevertheless, a physician's consultation to determine the underlying cause of your back pain is necessary before commencing treatment. Avoid self-administering Adiprox-DT Tablets, as the etiology of back pain varies individually.
Affirmative. Adiprox-DT Tablets are indicated for acute gout management. Clinical trials demonstrate significant efficacy of Adiprox-DT Tablets in treating acute gout attacks.
Blood donation is permissible while taking Adiprox-DT Tablets; however, it's crucial to disclose your medication to the physician prior to donation.
Piroxicam, as found in Adiprox-DT tablets, should only be used by diabetic patients under strict medical supervision. Prolonged use of this medication carries a significant risk of inducing kidney failure. Given that diabetes is an independent risk factor for renal impairment, the addition of piroxicam substantially elevates the likelihood of this adverse effect.
Individuals with impaired kidney function should avoid Adiprox-DT Tablets. Prolonged use of NSAIDs is linked to kidney damage, including papillary necrosis.
Affirmative. Adiprox-DT Tablet has been associated with cutaneous adverse reactions, potentially severe including exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN), the latter of which can be life-threatening. These serious reactions may develop unexpectedly. Report any mild skin eruption to your physician and cease medication immediately.
Adiprox-DT Tablets are contraindicated during pregnancy. Their use is associated with premature ductus arteriosus closure, potentially resulting in fetal cardiac failure and mortality.
Adiprox-DT Tablets are not to be used by patients with active peptic ulcers. This medication has been associated with gastric ulceration and hemorrhage.
Individuals with asthma may experience heightened sensitivity to nonsteroidal anti-inflammatory medications, such as aspirin, potentially triggering severe asthma episodes. Physician consultation is advised prior to commencing treatment with these drugs.
Confirmation: Adiprox-DT Tablets may induce temporary infertility in some cases. Piroxicam's mode of action can potentially hinder or inhibit ovarian follicle release, a factor linked to reversible infertility. Physician consultation is recommended prior to commencing treatment.
Adiprox-DT Tablets are contraindicated for concurrent use with diuretics. In certain individuals, Adiprox-DT Tablets diminish the sodium-excreting action of furosemide and thiazide diuretics. This effect is believed to result from the suppression of renal prostaglandin production.
Concomitant use of Adiprox-DT Tablet and lithium is contraindicated. Adiprox-DT Tablet increases plasma lithium concentrations and decreases lithium's renal clearance. This effect stems from the NSAID's inhibition of renal prostaglandin production. Physician consultation is mandatory prior to initiating Adiprox-DT Tablet therapy.
Concurrent use of Adiprox-DT tablets and warfarin is contraindicated due to the heightened risk of hemorrhage. Patients should disclose warfarin use to their physician before commencing Adiprox-DT therapy. If co-administered, close medical supervision is essential.
Individuals using corticosteroids or anticoagulants face a heightened risk of developing gastric ulcers. Prolonged medication use, alcohol consumption, smoking, and advanced age are additional contributing factors to this increased risk.
Individuals experiencing asthma, hives, or other allergic reactions to aspirin, other NSAIDs, or pain medication, either immediately preceding or following cardiac bypass surgery.
Gastrointestinal upset is possible, and in rare instances, severe gastrointestinal adverse events, including ulcers and hemorrhage, may occur. Serious dermatological reactions such as exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis, along with hepatic failure and kidney impairment, are also potential side effects.
3,018 People bought this recently
Adiprox-DT Tablet
57
MRP 70
18% off